| NCT ID | NCT06022653 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Asan Medical Center |
| Condition | Aorta Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,000 participants |
| Start Date | 2023-09-20 |
| Primary Completion | 2034-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,000 participants in total. It began in 2023-09-20 with a primary completion date of 2034-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the clinical results of patients who received revascularization of the aorta and peripheral artery at Asan Medical Center.
Eligibility Criteria
Inclusion Criteria: * Patients underwent Revascularization of Aorta or Peripheral artery from 2011 at the Peripheral Vascular Disease Center, Asan Medical Center * Patients with aortic and peripheral artery disease are defined as: Thoacic aorta disease/ abdominal aorta disease 1. Aneurysm 2. Aortic dissection 3. Penetrating aortic ulcer Peripheral artery occlusive disease 1. Chronic Limb-Threatening Ischemia 2. Claudication 3. Acute limb ischemia Exclusion Criteria: * For prospective cohort, not agreeing to participate with written informed consent form
Contact & Investigator
Seung-Whan Lee
PRINCIPAL INVESTIGATOR
Asan Medical Center
Frequently Asked Questions
Who can join the NCT06022653 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Aorta Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06022653 currently recruiting?
Yes, NCT06022653 is actively recruiting participants. Contact the research team at nurse9726@amc.seoul.kr for enrollment information.
Where is the NCT06022653 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT06022653 clinical trial?
NCT06022653 is sponsored by Asan Medical Center. The principal investigator is Seung-Whan Lee at Asan Medical Center. The trial plans to enroll 6,000 participants.